We are delighted to announce the renewal of our partnership with Menarini Group, which will be joining us as a Gold Sponsor for Frontiers Health 2025. This collaboration underscores our shared commitment to advancing healthcare innovation and improving patient outcomes. 

The Menarini Group is a pharmaceutical and diagnostics company headquartered in Florence, operating in 140 countries worldwide. With consolidated revenues of €4.603 billion and more than 17,000 employees, the company operates 9 R&D centers and is active in major therapeutic areas including cardiology, oncology, gastroenterology, pulmonology, infectious diseases, diabetology, inflammation, and analgesia. Pharmaceutical production is carried out in 18 manufacturing sites located in Italy and abroad, producing and distributing over 609 million packs annually across five continents. Menarini's manufacturing excellence consistently contributes to global patient health with the highest quality standards. 

This partnership firmly establishes Menarini's unwavering commitment to digital transformation within the biopharmaceutical industry. The company is actively prioritizing the advancement of digital capabilities across its entire organization, recognizing the vital role of technology in modern healthcare delivery. By embracing digital technology, Menarini is not only upskilling its workforce with critical digital health knowledge but is also driving digital health innovation to better anticipate evolving customer needs and optimize the customer experience. The Group views this digital focus as a crucial catalyst for holistic transformation, equipping it to deliver exceptional service and solidify its position as a leader in the digital health space. 

Dr. Steven Januar Kusmanto, MM (Global Director, Digital & Customer Engagement) and Davide Covello (Global Digital, Customer Engagement & Omnichannel Manager), affirm, "This collaboration aligns with our vision to deploy cutting-edge digital innovation and advanced capabilities to deliver optimal customer experiences across the healthcare ecosystem, accelerating digital transformation while upskilling our people to meet the future of patient care." 

Join us at FH25 in Berlin to discover how Menarini Pharmaceutical Group is leading the way in digital transformation!